GeneGo Launches New Search Product – Eureka! Available on Your iPhone
ST. JOSEPH, Mich., Nov. 16 /PRNewswire/ — GeneGo, Inc., the leading systems biology tools company, announced today the release of a stand alone search product, Eureka! It provides a simple one-button one-window access to GeneGo’s manually curated databases. Users can query the database with gene, protein, compound, drug names, diseases, and processes, pathological or toxic categories in a free text format. The results, ranked based on relevance, will present all categories of information and data from the database and links to external databases including third party vendors such as Sigma Aldrich. Eureka! is readily available and can be accessed from work, home, even on your iPhone. So users can get the answers they need at any time.
GeneGo will also provide FREE copies of Eureka! to anyone who recommends it to two people that purchase it.
“Eureka! is our entry-level product intended for the ‘mass market’, which is extremely easy to use, yet supported by the wealth of knowledge we have accumulated in our databases over 10 years,” said Julie Bryant, GeneGo’s VP of Business Development. “We already have over 75 orders for Eureka!, mainly from bench scientists and managers who want to find high quality information quickly without having to learn how to use software.”
About GeneGo, Inc.
GeneGo, Inc. develops systems biology technology such as compound based pathway analysis, cheminformatics & bioinformatics software for life science research. The original computational MetaDiscovery(TM) platform allows an integration and expert analysis of different kinds of experimental data (mRNA expression, proteomics, metabolomics, microRNA assays and other phenotypic data) and relevant bioactive chemistry (metabolites, drugs, other xenobiotics) within the framework of curated biological pathways and networks. GeneGo’s flagship product, MetaCore 6.0(TM), assists pharmaceutical scientists in the areas of target selection and validation, data mining in biology, identification of biomarkers for disease states and toxicology. The second product, MetaDrug 6.0(TM) is designed for prediction of human metabolism, toxicity and biological effects for novel small molecules compounds. MetaBase(TM) represents the knowledge base for MetaCore.
For more information, please visit the company’s web site at www.genego.com .
